Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-23 Purchase |
2024-12-27 5:17 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Carter Denise P. Chief Operating Officer |
555,556 | $0.45 | $250,000 | 1,713,760 (Direct) |
View |
| 2024-12-23 Purchase |
2024-12-27 5:16 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
555,556 | $0.45 | $250,000 | 1,713,920 (Direct) |
View |
| 2024-12-23 Purchase |
2024-12-27 5:16 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
122,221 | $0.45 | $54,999 | 395,519 (Direct) |
View |
| 2024-12-23 Purchase |
2024-12-27 5:15 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director |
100,000 | $0.45 | $45,000 | 300,317 (Direct) |
View |
| 2024-09-09 Purchase |
2024-09-11 4:30 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
28,856 | $0.80416 | $23,205 | 28,856 (Direct) |
View |
| 2024-09-03 Purchase |
2024-09-05 12:06 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Carter Denise P. Chief Operating Officer |
37,735 | $0.76155 | $28,737 | 47,092 (Direct) |
View |
| 2024-09-03 Purchase |
2024-09-05 12:03 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
37,894 | $0.76308 | $28,916 | 47,252 (Direct) |
View |
| 2024-06-07 Sale |
2024-06-10 4:10 pm |
Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director |
297 | $0.732 | $217 | 53 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-09 Option Award |
2024-12-10 4:52 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Cooper Joseph Patrick Director |
50,714 | $0 | 50,714 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:51 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
338,994 | $0 | 338,994 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:50 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director |
50,714 | $0 | 50,714 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:49 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Carter Denise P. Chief Operating Officer |
536,609 | $0 | 536,609 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:47 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | SEMBER MICHAEL T Director |
50,714 | $0 | 50,714 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:47 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
536,603 | $0 | 536,603 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:46 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Leong Natalie Ee Mun Director |
50,714 | $0 | 50,714 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:45 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director |
50,714 | $0 | 50,714 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:14 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | SEMBER MICHAEL T Director |
7,652 | $0 | 7,652 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:12 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
51,149 | $0 | 51,149 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:11 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
80,965 | $0 | 80,965 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:10 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director |
7,652 | $0 | 7,652 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:08 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Cooper Joseph Patrick Director |
7,652 | $0 | 7,652 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:08 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Leong Natalie Ee Mun Director |
7,652 | $0 | 7,652 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:06 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Carter Denise P. Chief Operating Officer |
80,966 | $0 | 80,966 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:05 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director |
7,652 | $0 | 7,652 (Direct) |
View |
Ownership |
2023-03-07 7:15 pm |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | SEMBER MICHAEL T Director |
0 | $0 | 64,285,600 (Direct) |
View |
Ownership(A) |
2023-03-07 7:13 pm |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director |
0 | $0 | 64,285,600 (Direct) |
View |
Ownership(A) |
2023-03-07 7:13 pm |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | Cooper Joseph Patrick Director |
0 | $0 | 64,285,600 (Direct) |
View |
Ownership(A) |
2023-03-07 7:13 pm |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director |
0 | $0 | 64,285,600 (Direct) |
View |
Ownership(A) |
2023-03-07 7:12 pm |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | Leong Natalie Ee Mun Director |
0 | $0 | 64,285,600 (Direct) |
View |
Ownership |
2023-01-03 09:47 am |
N/A N/A |
Quoin Pharmaceuticals Ltd. | QNRX | Myers Michael Chief Executive Officer |
0 | $0 | 990,051,600 (Direct) |
View |
Ownership |
2023-01-03 09:45 am |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | Cooper Joseph Patrick Director |
0 | $0 | 64,285,600 (Direct) |
View |
Ownership |
2023-01-03 09:43 am |
N/A N/A |
Quoin Pharmaceuticals Ltd. | QNRX | Carter Denise P. Chief Operating Officer |
0 | $0 | 990,046,600 (Direct) |
View |
Ownership |
2023-01-03 09:40 am |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
0 | $0 | 357,142,800 (Direct) |
View |
Ownership |
2023-01-03 09:38 am |
N/A N/A |
Quoin Pharmaceuticals Ltd. | QNRX | Culverwell Anthony James Director |
0 | $0 | 83,355,600 (Direct) |
View |
Ownership |
2023-01-03 09:37 am |
N/A N/A |
Quoin Pharmaceuticals Ltd. | QNRX | LANGER DENNIS Director |
0 | $0 | 85,290,600 (Direct) |
View |
Ownership |
2023-01-03 09:33 am |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | Leong Natalie Ee Mun Director |
0 | $0 | 64,285,600 (Direct) |
View |